The extensive and logically structured report examines what research is needed to support the risk regulation of nanotechnologies. Attention is restricted to poorly soluble, engineered particles that may be encountered during manufacture or as free particles in a product and which have the potential to persist once in the body. In our view, a significant absence from the plan is the understanding of the mode of action of the nano particles; i.e. those actions which make them commercially exploitable.
Evidence from:
BfR August 2006
“DRAFT: Nanotechnology: Health and Environmental Risks of Nanoparticles– Research strategy”
The research needs identified are based entirely on classical toxicology and exposure assessment concepts e.g. surface area, bio persistence, surface reactivity, stereochemistry. There is no mention of risk assessment for the intended property or action of the nano engineered product. The rationale is based on passive properties.
Further detail: